Pueraria Mirifica
Price
Ksh2599.00
Pueraria Mirifica
Key Benefits
- Pueraria mirifica (White Kwao Krua) is a Thai botanical containing miroestrol and deoxymiroestrol — phytoestrogens with the highest known estrogenic activity of any plant compound, estimated at 3,000 times the potency of soy isoflavones. These compounds selectively bind to estrogen receptors, providing estrogen-like activity without synthetic hormones.
- Significantly reduces the frequency and severity of vasomotor menopausal symptoms including hot flashes and night sweats by providing phytoestrogenic stimulation of hypothalamic thermoregulatory centers that normally depend on endogenous estrogen signaling.
- Supports vaginal health and comfort during menopause by stimulating estrogen receptors in vaginal epithelial cells — reversing vaginal atrophy and dryness caused by estrogen withdrawal, which affects approximately 45% of postmenopausal women.
- Antioxidant activity: Pueraria mirifica contains high concentrations of isoflavones (genistein, daidzein, puerarin) that exhibit direct free radical scavenging activity and stimulate endogenous antioxidant enzyme production, reducing oxidative stress biomarkers.
- Supports bone mineral density in estrogen-deficient women by activating ERa and ERb (estrogen receptor alpha and beta) on osteoblasts, stimulating bone formation while inhibiting osteoclast-mediated bone resorption — the same mechanism as estrogen itself.
- May support cardiovascular health in postmenopausal women by improving lipid profiles (reducing LDL, increasing HDL) and improving endothelial function through estrogenic activity on vascular smooth muscle — addressing the cardiovascular risk that escalates sharply with estrogen decline after menopause.
- The 10,000 mg label dose reflects an extract equivalency to 10,000 mg of raw herb — the actual concentrated extract per capsule is substantially smaller. This is standard herbal industry labeling practice for standardized extracts.
Recommended Usage
Scientific Backing
- Menopausal Symptoms: A double-blind RCT in Climacteric (Lamlertkittikul & Chandeying, 2004) found Pueraria mirifica vaginal cream significantly improved vaginal atrophy scores and reduced hot flash frequency versus placebo over 24 weeks.
- Phytoestrogenic Potency: Pharmacological studies (Chansakaow et al., Journal of Natural Products, 2000) confirmed miroestrol as the primary estrogenic compound in Pueraria mirifica, with binding affinity to estrogen receptors comparable to estradiol.
- Bone Protection: Animal studies published in the British Journal of Nutrition show Pueraria mirifica supplementation prevented ovariectomy-induced bone loss to a similar degree as estrogen replacement therapy, with effects on bone mineral density and microarchitecture.
- Cardiovascular: A 2007 controlled study (Manonai et al., Gynecological Endocrinology) found Pueraria mirifica supplementation significantly improved total cholesterol, LDL, and HDL profiles in postmenopausal women over 24 weeks.
- Safety Note: Unlike synthetic HRT, Pueraria mirifica primarily activates ERb receptors (which are cardioprotective) with less ERa activity (which drives breast tissue stimulation), suggesting a potentially more favorable safety profile — though long-term safety data is still being established.